| Not Yet Recruiting | A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease NCT07377565 | Nielsen Fernandez-Becker | Phase 1 |
| Not Yet Recruiting | Small Bowel Ultrasound and Antibody Levels in Celiac Disease Activity NCT07453589 | Assiut University | — |
| Not Yet Recruiting | Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients NCT07366151 | Tampere University Hospital | — |
| Recruiting | Study of DONQ52 in Active Celiac Disease NCT07239336 | Chugai Pharmaceutical | Phase 2 |
| Recruiting | A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease NCT07063823 | Nielsen Fernandez-Becker | Phase 1 |
| Recruiting | Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease NCT06982963 | Forte Biosciences, Inc. | Phase 2 |
| Recruiting | Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response? NCT07039773 | Oslo University Hospital | N/A |
| Recruiting | The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality NCT07177287 | Ankara Yildirim Beyazıt University | N/A |
| Recruiting | Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients NCT07069127 | University of Pavia | N/A |
| Recruiting | Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease NCT07362654 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | N/A |
| Recruiting | Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease NCT07070596 | Hospital Mutua de Terrassa | — |
| Active Not Recruiting | A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease NCT06807463 | Teva Branded Pharmaceutical Products R&D LLC | Phase 2 |
| Enrolling By Invitation | Enabling Microbiomics- Driven Personalized Nutrition NCT06657001 | Mayo Clinic | — |
| Recruiting | AI System for Detection and Characterization of Chronic Enteropathies NCT07387185 | Istituti Clinici Scientifici Maugeri SpA | — |
| Recruiting | Gluten Technology and Education for Celiac Health NCT06059716 | Columbia University | N/A |
| Recruiting | Urine Metabolites in the Diagnosis of Disease NCT06710067 | Luventix, Inc. | — |
| Active Not Recruiting | A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac NCT06557772 | Sanofi | Phase 2 |
| Recruiting | VTP-1000 in Adults With Celiac Disease NCT06310291 | Barinthus Biotherapeutics | EARLY_Phase 1 |
| Recruiting | Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease NCT07298343 | Dr. Falk Pharma GmbH | Phase 2 |
| Completed | Supporting Children and Young People to Live Well with Coeliac Disease NCT06007898 | University of Surrey | N/A |
| Unknown | The Effect of Unripe Carob Fruit in Celiac Patients NCT06300164 | Toros University | N/A |
| Completed | The Effect of Hazelnut Flour on Blood Glucose NCT06382506 | Ege University | N/A |
| Not Yet Recruiting | Assessment of Coeliac Disease in Patients With Type 2 Diabetes NCT06283264 | Assiut University | — |
| Active Not Recruiting | Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS NCT06908057 | AdventHealth Translational Research Institute | — |
| Unknown | Celiac Disease Among Egyptian Children With Unexplained Short Stature NCT06164548 | Assiut University | — |
| Completed | Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients? NCT06151782 | Oslo University Hospital | N/A |
| Completed | A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease NCT06001177 | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | Phase 2 |
| Recruiting | Tissue Destruction and Healing in Celiac Disease NCT05680012 | University of Chicago | N/A |
| Recruiting | Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620 | Brain Inflammation Collaborative | — |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Recruiting | Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases NCT05904301 | Santé Arménie French-Armenian Research Center | — |
| Completed | ICT Tools for the Diagnosis of Autoimmune Diseases NCT05715970 | University of Palermo | N/A |
| Unknown | RCT: Effect of Late vs Early Introduction of Gluten-free Oats on Patients With Newly Diagnosed Celiac Disease. NCT05803408 | McMaster University | N/A |
| Recruiting | Gfree - For Improved Blood Sugar and Reduced Inflammation. NCT05894746 | Göteborg University | N/A |
| Unknown | Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients NCT05825976 | Josip Juraj Strossmayer University of Osijek | N/A |
| Completed | A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celia NCT05686369 | Chugai Pharmaceutical | — |
| Completed | Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Pati NCT05636293 | Massachusetts General Hospital | Phase 2 |
| Recruiting | Development of New Diagnostic Tools in Capsule Endoscopy NCT06152289 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Irritable Bowel Syndrome Overlaping Celiac Disease NCT05740306 | Centre of Postgraduate Medical Education | — |
| Recruiting | Immune Responses to Gluten NCT05209568 | Boston Children's Hospital | N/A |
| Recruiting | Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis NCT05633706 | Nimble Science Ltd. | — |
| Recruiting | A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune NCT06587828 | TScan Therapeutics, Inc. | — |
| Recruiting | No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays NCT05983978 | Instituto de Investigación Hospital Universitario La Paz | — |
| Completed | A Study to Assess the Safety of TPM502 in Adults With Celiac Disease NCT05660109 | Topas Therapeutics GmbH | Phase 2 |
| Unknown | Zinc Deficiency Treatment in Celiac Disease: Supplementation Versus Diet NCT05782257 | McMaster University | N/A |
| Recruiting | Tryptophan for Impaired AhR Signaling in Celiac Disease NCT05576038 | McMaster University | N/A |
| Unknown | Probiotic Blend for Celiac Disease NCT05646823 | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Phase 2 |
| Terminated | A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) NCT05574010 | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | Phase 1 / Phase 2 |
| Recruiting | Background of Different Phenotypes of Coeliac Disease NCT05597904 | Tampere University Hospital | — |
| Unknown | FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE NCT05581628 | Bezmialem Vakif University | — |
| Suspended | Bovine Colostrum to Prevent Absorption of Gluten NCT05555446 | Milky Way Life Sciences LLC | EARLY_Phase 1 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients NCT05425446 | Chugai Pharmaceutical | Phase 1 |
| Completed | Virtual Celiac Symptoms Study in Adults and Teenagers NCT05309330 | Takeda | — |
| Completed | A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet NCT05353985 | Takeda | Phase 2 |
| Completed | Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation i NCT04530123 | Takeda | Phase 2 |
| Enrolling By Invitation | Behavioral Intervention for Celiac Disease NCT05204446 | Children's National Research Institute | N/A |
| Completed | Assessing the Histological Quality of Biopsy Samples Obtained With Multibite Forceps NCT05227079 | Lawrence Charles Hookey | N/A |
| Active Not Recruiting | Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients NCT06178107 | University of Roehampton | N/A |
| Unknown | Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) NCT05114278 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Unknown | Impact of a Low-FODMAP Gluten-free Diet on Gut Microbiota and Circulating miRNAs in Celiac Disease Patients NCT04655495 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | Educational Intervention on Celiac Disease and Gluten-free Diet Through Social Networks (GLUTLEARN Project). NCT05923346 | University of the Basque Country (UPV/EHU) | N/A |
| Completed | Gluten Free Oat (Cultivar Saul) in Celiac Disease in Remission NCT07515105 | Faculty Hospital Kralovske Vinohrady | N/A |
| Recruiting | Persistent Villous Atrophy in Celiac Disease Patients Following an Intentionally Strict Gluten-free Diet NCT06500754 | Hospital Mutua de Terrassa | — |
| Completed | Mass Screening for the Early Detection of Patients With Celiac Disease. NCT05186038 | Biomedal S.L. | — |
| Enrolling By Invitation | Celiac Disease in Childhood-Adulthood Transition NCT05084937 | Tampere University Hospital | N/A |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Unknown | Prevalence of Renal Disease in Children With Celiac Disease NCT05049876 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Virtual Chromoendoscopy With Magnification in Coeliac Disease. NCT05103150 | Instituto Ecuatoriano de Enfermedades Digestivas | — |
| Completed | Glutenfree, Gut Microbiota and Metabolic Regulation NCT05135923 | Oslo Metropolitan University | N/A |
| Withdrawn | A Study of Guselkumab in Adult Participants With Celiac Disease NCT04704843 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease NCT04806737 | Oslo University Hospital | Phase 1 / Phase 2 |
| Terminated | Study of Latiglutenase in T1D/CD Patients NCT04839575 | Entero Therapeutics | Phase 2 |
| Suspended | Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence NCT05119322 | Biomedal S.L. | N/A |
| Completed | AN-PEP on Gluten Exposure in Celiacs NCT04788797 | Dr. C. Bonorino Udaondo Gastroenterology Hospital | Phase 4 |
| Unknown | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up NCT04789993 | Central Hospital, Nancy, France | — |
| Completed | PTG-100 for Patients With Celiac Disease NCT04524221 | Nielsen Fernandez-Becker | Phase 1 |
| Completed | Quality of Life and Eating Disorders in Children With FPIES, Food Allergy or Celiac Disease NCT04643704 | Assistance Publique - Hôpitaux de Paris | — |
| Enrolling By Invitation | Combined Antibody Screening for Celiac and Diabetes Evaluation NCT04677699 | Pacific Northwest Research Institute | — |
| Completed | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to NCT04604795 | GlaxoSmithKline | Phase 1 |
| Completed | T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Glu NCT04614571 | Regeneron Pharmaceuticals | N/A |
| Unknown | Coeliac Disease in Spain: Determination of Disease Prevalence and Risk Factors NCT05094232 | Hospital Mutua de Terrassa | — |
| Active Not Recruiting | Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease NCT05548166 | McMaster University | — |
| Active Not Recruiting | Metabolic Control and Glycemic Variability in Type 1 Diabetes and Celiac Disease NCT06717841 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet. NCT04477239 | Università Politecnica delle Marche | N/A |
| Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata NCT04239521 | Momentum Data | — |
| Completed | Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects Wi NCT04593251 | Calypso Biotech BV | Phase 1 |
| Completed | Gluten Challenge Study in Celiac Disease Participants (MK-0000-402) NCT04054544 | Merck Sharp & Dohme LLC | EARLY_Phase 1 |
| Completed | PRV-015 in Gluten-free Diet Non-responsive Celiac Disease NCT04424927 | Provention Bio, a Sanofi Company | Phase 2 |
| Recruiting | General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery NCT04477928 | Sanford Health | — |
| Completed | Celiac Disease: Nutrition Education in Primary School NCT05467865 | University of the Basque Country (UPV/EHU) | N/A |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Celiac Disease NCT04148235 | ProgenaBiome | — |
| Completed | Experiences of Disclosure in Adolescents With Coeliac Disease NCT04240340 | University of Oxford | — |
| Recruiting | Pathogenic Study of Adult Immune Enteropathies NCT04280510 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | Assessment of KAN-101 in Celiac Disease (ACeD) NCT04248855 | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | Phase 1 |
| Terminated | Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients NCT04243551 | Entero Therapeutics | Phase 2 |
| Completed | A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celi NCT03707730 | Igy Inc. | Phase 2 |
| Completed | Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis NCT05810441 | IRCCS Burlo Garofolo | — |
| Terminated | Budesonide in Patients With Immune Mediated Enteropathies NCT03866538 | Mayo Clinic | Phase 4 |
| Recruiting | Safety and Efficacy of Fecal Microbiota Transplantation NCT04014413 | Chinese University of Hong Kong | N/A |
| Suspended | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469 | ProgenaBiome | — |
| Completed | Coeliac Disease in the Nord-Trøndelag Health Study (HUNT) NCT04041622 | Norwegian University of Science and Technology | N/A |
| Terminated | Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms NCT03569007 | 9 Meters Biopharma, Inc. | Phase 3 |
| Withdrawn | Capsule Endoscopy in Newly Diagnosed Patients of Celiac Disease NCT03731806 | Tazeen Rasheed | — |
| Unknown | Fluorescence Spectroscopy for Gut Permeability Assessment NCT03434639 | Imperial College London | — |
| Completed | Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease NCT03857360 | Università Politecnica delle Marche | N/A |
| Completed | Latiglutenase as a Treatment for Celiac Disease NCT03585478 | Immunogenics, LLC | Phase 2 |
| Unknown | Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Di NCT05066191 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Unknown | Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in NCT04160767 | University of Milan | Phase 4 |
| Active Not Recruiting | Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up S NCT04958356 | University of Helsinki | — |
| Completed | Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease NCT03738475 | Takeda | Phase 2 |
| Completed | Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease NCT04351828 | Marmara University | — |
| Completed | Effects of Gluten-Free Diet on Nutritional Status in Celiac Patients NCT06402734 | Hacettepe University | — |
| Completed | Probiotic BL NCC 2705 and Gluten Sensitivity NCT03775499 | Société des Produits Nestlé (SPN) | N/A |
| Completed | Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients NCT03678935 | Oslo University Hospital | N/A |
| Completed | Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women NCT05052164 | University of Alicante | N/A |
| Unknown | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) NCT03644069 | ImmusanT, Inc. | Phase 2 |
| Terminated | Vedolizumab Induction May Prevent Celiac Enteritis NCT02929316 | AGA Clinical Research Associates, LLC | Phase 2 |
| Unknown | The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation ("Marginal-zone-like") NCT03763487 | University Hospital Hradec Kralove | N/A |
| Completed | A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease NCT03521180 | Celgene | — |
| Completed | Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease NCT03543540 | ImmusanT, Inc. | Phase 1 |
| Completed | Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge NCT03409796 | Takeda | N/A |
| Suspended | Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease NCT03462979 | Boston Children's Hospital | N/A |
| Unknown | Gluten Related Disorders in Barrett's Esophagus NCT03329534 | McMaster University | N/A |
| Completed | Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease NCT03486990 | Takeda | Phase 1 |
| Completed | Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease NCT03321214 | Columbia University | N/A |
| Enrolling By Invitation | Evidence-based Screening Strategies for Celiac Disease NCT03136731 | Katri Kaukinen | — |
| Unknown | Differences in Preparation for Small Bowel Capsule Endoscopy NCT03351972 | Sheffield Teaching Hospitals NHS Foundation Trust | Phase 4 |
| Completed | Changes in Intestinal Permeability 4 Hours After Gluten Challenge NCT03288831 | Mayo Clinic | N/A |
| Completed | Near-Focus NBI Classification of Villous Atrophy in Suspected Coeliac Disease: International Development and V NCT04349904 | King's College Hospital NHS Trust | — |
| Completed | Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Ga NCT03271138 | Global Institute of Probiotics | Phase 2 |
| Completed | Celiac Disease and Diabetes Longitudinal Follow-up and Evaluation Study NCT03122093 | The Hospital for Sick Children | — |
| Completed | Fecal Calprotectin Collection Protocol NCT03143517 | DiaSorin Inc. | — |
| Completed | Gluten Challenge in Celiac Disease NCT02464150 | Oslo University Hospital | N/A |
| Completed | "Gluten Friendly" Treatment in Celiac Disease NCT03137862 | Casa Sollievo della Sofferenza IRCCS | N/A |
| Unknown | Comparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac Disease NCT03095573 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal a NCT03051204 | University of California, Los Angeles | — |
| Completed | Can Celiac Disease Affect Ovarian Function in Adolescent? NCT04024449 | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | — |
| Completed | Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients NCT03483805 | Société Guaranteed Gluten Free (GGF) | N/A |
| Completed | Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance NCT03152279 | Vanderbilt University Medical Center | — |
| Completed | A 12-week Exercise Program for Adults With Celiac Disease NCT03520244 | University of Calgary | N/A |
| Completed | Hookworm Therapy for Coeliac Disease NCT02754609 | James Cook University, Queensland, Australia | Phase 1 |
| Unknown | Prucalopride Prior to Small Bowel Capsule Endoscopy NCT02806206 | University of British Columbia | Phase 4 |
| Completed | Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease NCT02805816 | Rabin Medical Center | — |
| Completed | Nutritional Intake and Bone Health in Celiac Disease NCT03364556 | George Mason University | — |
| Completed | A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease NCT02637141 | Amgen | Phase 2 |
| Completed | A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosi NCT02679014 | Hoffmann-La Roche | Phase 1 |
| Completed | Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] NCT03011931 | Entero Therapeutics | EARLY_Phase 1 |
| Completed | Gut Permeability Assessment in Celiac and Gluten Sensitive Children NCT02690532 | Mayo Clinic | — |
| Terminated | In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease NCT03168490 | University of Roehampton | N/A |
| Completed | Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children NCT03064997 | Polish Academy of Sciences | N/A |
| Unknown | A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms NCT02946827 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | MAgnetic Resonance Imaging in COeliac Disease NCT02551289 | University of Nottingham | — |
| Unknown | Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease NCT02949765 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | Effect of UGIR in Adults With Compromised Gut Function and Malabsorption NCT03011593 | Metagenics, Inc. | N/A |
| Completed | Safety and Tolerability of Oat Containing Gluten-free Diet NCT02612766 | Alfred Rusescu Institute for Mother and Child Care | N/A |
| Completed | Fiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease NCT03380988 | Federico II University | N/A |
| Completed | Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System NCT04573959 | Capso Vision, Inc. | N/A |
| Completed | Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease NCT02528799 | ImmusanT, Inc. | Phase 1 |
| Terminated | Assessing Neurocognitive Effects of Gluten Exposure NCT01506349 | Beth Israel Deaconess Medical Center | N/A |
| Unknown | Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease NCT02472119 | University of Roma La Sapienza | Phase 2 |
| Terminated | Pancreatic Enzyme Supplementation for Celiac Disease NCT02475369 | Beth Israel Deaconess Medical Center | Phase 4 |
| Completed | SCREENING OF CELIAC DISEASE IN SCHOLAR CHILDREN IN ITALY NCT04867863 | Università Politecnica delle Marche | — |
| Unknown | Sucrosomial Iron in Patients With Celiac Disease and IDA NCT02916654 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease NCT02458898 | Stanford University | N/A |
| Completed | Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibo NCT03320811 | CHU de Reims | — |
| Completed | Celiac Disease and Infertility Among Men and Women in Denmark NCT02451449 | University of Aarhus | — |
| Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study NCT04306939 | University of Pittsburgh | — |
| Completed | Oral AGY for Celiac Disease NCT01765647 | Igy Inc. | Phase 1 |
| Completed | Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [Gl NCT02711696 | Università degli Studi di Brescia | N/A |
| Terminated | Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting NCT02036944 | Providence Medical Research Center | — |
| Recruiting | Celiac Disease Genomic Environmental Microbiome and Metabolomic Study NCT02061306 | Massachusetts General Hospital | — |
| Completed | Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. NCT01990885 | BioLineRx, Ltd. | Phase 1 / Phase 2 |
| Completed | Cytokine Profile in Children With Celiac Disease NCT02244047 | University Medical Centre Maribor | Phase 1 / Phase 2 |
| Enrolling By Invitation | Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule NCT02202681 | Massachusetts General Hospital | N/A |
| Terminated | Celiac Disease Screening NCT01902368 | Beth Israel Deaconess Medical Center | N/A |
| Unknown | Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients NCT01917630 | Alvine Pharmaceuticals Inc. | Phase 2 |
| Completed | Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes NCT01932476 | Joslin Diabetes Center | N/A |
| Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo NCT01931644 | Sanguine Biosciences | — |
| Completed | Antibody Treatment for Advanced Celiac Disease NCT01893775 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Dietary Assessment and Mycotoxin Exposure in Celiac Disease NCT01975155 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Completed | Gluten-free Diet Monitoring in Urine NCT02344758 | University of Seville | EARLY_Phase 1 |
| Completed | Immune Response in Celiac Disease on In-vitro Gluten Challenge NCT01909050 | Beth Israel Deaconess Medical Center | — |
| Completed | INF-α Innate Immune Response to Gliadin NCT03221647 | Federico II University | — |
| Completed | TCRγδ+ Cells After Gluten-free Diet: A Biomarker for Coeliac Disease? NCT05733663 | Hospital Mutua de Terrassa | — |
| Completed | A Population-based Study of Celiac Disease in South Europe in Children Between 1 to 5 Years of Age NCT05968404 | Hospital Mutua de Terrassa | — |
| Completed | Screen-detected Coeliac Disease, a Population Based Study NCT01695681 | University Hospital of North Norway | N/A |
| Completed | Desensitising Celiac Disease Patients With the Human Hookworm NCT01661933 | The Prince Charles Hospital | Phase 1 / Phase 2 |
| Terminated | Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration NCT01642862 | University of Zurich | Phase 1 |
| Completed | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Diseas NCT01787825 | Capso Vision, Inc. | N/A |
| Completed | Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome NCT01574209 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | — |
| Completed | Quantification of Gluten Peptides in Feces NCT02711397 | Biomedal S.L. | — |
| Completed | Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients NCT01560169 | Alvine Pharmaceuticals Inc. | — |
| Completed | Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial NCT01566110 | The Hospital for Sick Children | N/A |
| Completed | Detection of Celiac Disease in Patients With Hypothyroidism NCT01862510 | University of Vermont | — |
| Unknown | Enteroscopy for Early Diagnosis of Tumors in Celiac Disease NCT02325232 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysiu NCT02242123 | University of Palermo | — |
| Completed | A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease NCT01396213 | 9 Meters Biopharma, Inc. | Phase 2 |
| Completed | Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo NCT02472704 | Hospital Mutua de Terrassa | N/A |
| Completed | Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City NCT02312349 | Hospital Italiano de Buenos Aires | — |
| Completed | Improved Diagnostics of Celiac Disease in Children NCT02072590 | Tampere University Hospital | — |
| Completed | Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin NCT01558570 | University of Maryland, Baltimore | — |
| Completed | Detection of Immunotoxic Gluten Peptides in Feces NCT01478867 | University of Seville | — |
| Unknown | Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients NCT01159457 | Shaare Zedek Medical Center | N/A |
| Completed | Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease NCT02190513 | St. John Health System, Michigan | — |
| Completed | Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease NCT01257620 | Bai, Julio M.D. | N/A |
| Completed | Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease NCT02220166 | Università degli Studi di Brescia | Phase 2 |
| Completed | Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease NCT01255696 | Alvine Pharmaceuticals Inc. | Phase 2 |
| Completed | Prospective Study of Undiagnosed Celiac Disease NCT01317914 | Mayo Clinic | N/A |
| Completed | Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet NCT01129908 | Hadassah Medical Organization | — |
| Completed | Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Di NCT01338324 | All India Institute of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing NCT02834429 | Sheffield Teaching Hospitals NHS Foundation Trust | — |
| Completed | Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Yo NCT01439035 | Massachusetts General Hospital | N/A |
| Completed | Safety and Efficacy of ALV003 for the Treatment of Celiac Disease NCT00959114 | Alvine Pharmaceuticals Inc. | Phase 2 |
| Completed | Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease NCT00889473 | 9 Meters Biopharma, Inc. | Phase 2 |
| Completed | Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients NCT01045837 | All India Institute of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Safety Study of Nexvax2 in Subjects With Coeliac Disease NCT00879749 | Nexpep Pty Ltd | Phase 1 |
| Completed | Serum Markers in Gluten Challenge NCT00931892 | Beth Israel Deaconess Medical Center | N/A |
| Terminated | Response to Hepatitis B Vaccine in Celiac Disease Patients NCT00739128 | Shaare Zedek Medical Center | N/A |
| Completed | Celiac Disease Database NCT01172665 | University of Chicago | — |
| Completed | Study of Enzyme Supplements to Treat Celiac Disease NCT00962182 | Heim Pal Children's Hospital | Phase 1 / Phase 2 |
| Completed | Treatment of Screen-detected Celiac Disease NCT01116505 | Tampere University Hospital | N/A |
| Completed | Gluten Free Diet in People With Schizophrenia: A Pilot Study NCT01558557 | University of Maryland, Baltimore | N/A |
| Completed | Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients NCT00810654 | Amsterdam UMC, location VUmc | Phase 1 / Phase 2 |
| Completed | Effects of Gluten Digestion With ALV003 NCT00859391 | Alvine Pharmaceuticals Inc. | — |
| Terminated | Infant Nutrition and Risk of Celiac Disease NCT00819819 | Massachusetts General Hospital | N/A |
| Completed | Predictive Genetic Risk Assessment Trial NCT00782366 | Mayo Clinic | — |
| Completed | Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Glute NCT00669825 | Alvine Pharmaceuticals Inc. | Phase 1 |
| Completed | Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Diseas NCT00620451 | 9 Meters Biopharma, Inc. | Phase 2 |
| Completed | A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-C NCT00626184 | Alvine Pharmaceuticals Inc. | Phase 1 |
| Unknown | Celiac Disease Prevention NCT00617838 | Kuopio University Hospital | N/A |
| Completed | A Phase II Study of CCX282-B in Patients With Celiac Disease NCT00540657 | Amgen | Phase 2 |
| Completed | Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten NCT00671138 | Princess Alexandra Hospital, Brisbane, Australia | Phase 2 |
| Completed | Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease NCT00492960 | 9 Meters Biopharma, Inc. | Phase 2 |
| Completed | Gluten-free Diet in Gluten-genetically Predisposed Subjects NCT00677495 | IRCCS Burlo Garofolo | N/A |
| Completed | Impact of the Diagnosis of Celiac Disease NCT01145287 | Tampere University Hospital | — |
| Completed | Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease NCT01137955 | Columbia University | N/A |
| Completed | Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects NCT00362856 | 9 Meters Biopharma, Inc. | Phase 2 |
| Completed | HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease NCT01100099 | Oslo University Hospital | Phase 2 / Phase 3 |
| Completed | Safety Study of Larazotide Acetate to Treat Celiac Disease. NCT00386165 | 9 Meters Biopharma, Inc. | Phase 1 |
| Completed | Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease? NCT00175760 | University of British Columbia | — |
| Completed | Risk of Celiac Disease and Age at Gluten Introduction NCT00639444 | Università Politecnica delle Marche | N/A |
| Completed | Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23) NCT00555737 | Medtronic - MITG | — |
| Completed | Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients NCT00138879 | St Mark's Hospital Foundation | — |
| Completed | Treatment of Mild Enteropathy Celiac Disease NCT00628823 | Tampere University Hospital | N/A |
| Terminated | Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease NCT00250146 | Università Politecnica delle Marche | N/A |
| Completed | Characteristics of Anemia in Celiac Disease NCT05172895 | University of Palermo | — |
| Completed | Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia NCT00006492 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184 | Mayo Clinic | — |
| No Longer Available | AMG 714 Expanded Access Program NCT03439475 | Amgen | — |
| Unknown | Telomeres Parameters in Celiac Disease NCT02126033 | Meir Medical Center | N/A |